文献速递银屑病与炎症性皮肤病

miR-378a调控银屑病中角质形成细胞对白细胞介素-17A的反应性

miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis.
PubMed 文献 · Br J Dermatol · 2022-05-25

研究探讨miR-378a在银屑病中的作用。银屑病皮损和健康表皮角质形成细胞经磁珠分选后,用定量聚合酶链反应分析miR-378a表达,并在原代人角质形成细胞及咪喹莫特诱导的小鼠银屑病样皮炎模型中研究其调控与功能。结果显示IL-17A通过NF-κB、C/EBP-β和IκBζ诱导角质形成细胞表达miR-378a,银屑病表皮中miR-378a过表达;miR-378a可促进p65核转位、增强NF-κB启动子活性并放大IL-17A效应,小鼠皮肤注射miR-378a可加重银屑病样炎症,机制上miR-378a抑制NFKBIA/IκBζ。

要点

  • IL-17A通过NF-κB、C/EBP-β和IκBζ诱导角质形成细胞表达miR-378a,银屑病表皮中miR-378a过表达。
  • miR-378a促进p65核转位并增强NF-κB启动子活性,且可放大IL-17A对NF-κB通路的激活。
  • 小鼠皮肤注射miR-378a可加重银屑病样炎症,机制为抑制NFKBIA/IκBζ。

核心结论

  • miR-378a是角质形成细胞中IL-17A诱导的NF-κB信号通路的放大因子,其水平升高可能促进银屑病中IL-17A驱动的皮肤炎症放大。

研究设计与样本

  • 研究纳入银屑病皮损与健康表皮来源的角质形成细胞(经磁珠分选),用定量聚合酶链反应分析miR-378a表达。
  • 在原代人角质形成细胞中通过合成mimics调控miR-378a表达,研究NF-κB活性与转录组变化。
  • 将合成miR-378a与咪喹莫特诱导的银屑病样皮肤炎症联合递送至小鼠皮肤。

主要发现

  • IL-17A通过NF-κB、C/EBP-β和IκBζ在角质形成细胞中诱导miR-378a,且银屑病表皮中miR-378a过表达。
  • 培养角质形成细胞中异位表达miR-378a导致p65核转位并增强NF-κB驱动的启动子活性,即使无炎症刺激。
  • miR-378a增强IL-17A对NF-κB核转位及下游NF-κB通路激活的效应。
  • 小鼠皮肤注射miR-378a加重银屑病样皮肤炎症,伴表皮增殖增加和炎症介质诱导。
  • 机制上miR-378a抑制NFKBIA/IκBζ,后者是角质形成细胞中NF-κB通路的重要负调控因子。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is an immune-mediated inflammatory skin disease, in which an interplay between infiltrating immune cells and keratinocytes sustains chronic skin inflammation. Interleukin (IL)-17A is a key inflammatory cytokine in psoriasis and its main cellular targets are keratinocytes. OBJECTIVES: To explore the role of miR-378a in psoriasis. METHODS: Keratinocytes obtained from psoriatic skin and healthy epidermis were separated by magnetic sorting, and the expression of miR-378a was analysed by quantitative polymerase chain reaction. The regulation and function of miR-378a was studied using primary human keratinocytes. The expression of miR-378a was modulated by synthetic mimics, and nuclear factor kappa B (NF-κB) activity and transcriptomic changes were studied. Synthetic miR-378a was delivered to mouse skin in conjunction with induction of psoriasiform skin inflammation by imiquimod. RESULTS: We show that miR-378a is induced by IL-17A in keratinocytes through NF-κB, C/EBP-β and IκBζ and that it is overexpressed in psoriatic epidermis. In cultured keratinocytes, ectopic expression of miR-378a resulted in the nuclear translocation of p65 and enhanced NF-κB-driven promoter activity even in the absence of inflammatory stimuli. Moreover, miR-378a potentiated the effect of IL-17A on NF-κB nuclear translocation and downstream activation of the NF-κB pathway. Finally, injection of miR-378a into mouse skin augmented psoriasis-like skin inflammation with increased epidermal proliferation and induction of inflammatory mediators. Mechanistically, miR-378a acts as a suppressor of NFKBIA/IκBζ, an important negative regulator of the NF-κB pathway in keratinocytes. CONCLUSIONS: Collectively, our findings identify miR-378a as an amplifier of IL-17A-induced NF-κB signalling in keratinocytes and suggest that increased miR-378a levels contribute to the amplification of IL-17A-driven skin inflammation in psoriasis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Xia P, Pasquali L, Gao C, et al. miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis. Br J Dermatol. 2022. PMID: 35257359. doi:10.1111/bjd.21232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。